Showing 20,301 - 20,320 results of 38,424 for search '(( significant ((nn decrease) OR (related disease)) ) OR ( significant decrease decrease ))', query time: 0.71s Refine Results
  1. 20301

    Table_4_Spatiotemporal patterns of rheumatic heart disease burden attributable to high systolic blood pressure, high sodium diet, and lead exposure (1990 to 2019): a longitudinal o... by Yanli Zhang (309699)

    Published 2024
    “…Background<p>Rheumatic heart disease (RHD) continues to be a significant global health concern, exhibiting unique regional disparities. …”
  2. 20302

    Table_1_Spatiotemporal patterns of rheumatic heart disease burden attributable to high systolic blood pressure, high sodium diet, and lead exposure (1990 to 2019): a longitudinal o... by Yanli Zhang (309699)

    Published 2024
    “…Background<p>Rheumatic heart disease (RHD) continues to be a significant global health concern, exhibiting unique regional disparities. …”
  3. 20303

    Table_6_Spatiotemporal patterns of rheumatic heart disease burden attributable to high systolic blood pressure, high sodium diet, and lead exposure (1990 to 2019): a longitudinal o... by Yanli Zhang (309699)

    Published 2024
    “…Background<p>Rheumatic heart disease (RHD) continues to be a significant global health concern, exhibiting unique regional disparities. …”
  4. 20304

    Table_5_Spatiotemporal patterns of rheumatic heart disease burden attributable to high systolic blood pressure, high sodium diet, and lead exposure (1990 to 2019): a longitudinal o... by Yanli Zhang (309699)

    Published 2024
    “…Background<p>Rheumatic heart disease (RHD) continues to be a significant global health concern, exhibiting unique regional disparities. …”
  5. 20305

    Presentation1_Tumor-related IGF2BP1-derived molecular subtypes to predict prognosis and immune microenvironment in head and neck squamous cell carcinoma.pdf by Qin Ding (657293)

    Published 2024
    “…Background<p>Recent studies have underscored the biological significance of RNA modifications in tumorigenicity and progression. …”
  6. 20306
  7. 20307

    Table 1_Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis.xlsx by Timothy Adeyemi (22652597)

    Published 2025
    “…Significant effect sizes (0.09 and −0.08) after 24 weeks were equally found in three studies, indicating the reduction in disease activity and an improvement in functionality, respectively. …”
  8. 20308

    Table 2_Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis.xlsx by Timothy Adeyemi (22652597)

    Published 2025
    “…Significant effect sizes (0.09 and −0.08) after 24 weeks were equally found in three studies, indicating the reduction in disease activity and an improvement in functionality, respectively. …”
  9. 20309

    Supplementary file 1_Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis.pdf by Timothy Adeyemi (22652597)

    Published 2025
    “…Significant effect sizes (0.09 and −0.08) after 24 weeks were equally found in three studies, indicating the reduction in disease activity and an improvement in functionality, respectively. …”
  10. 20310

    Data Sheet 1_Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis.pdf by Timothy Adeyemi (22652597)

    Published 2025
    “…Significant effect sizes (0.09 and −0.08) after 24 weeks were equally found in three studies, indicating the reduction in disease activity and an improvement in functionality, respectively. …”
  11. 20311

    Table 3_Efficacy of pharmacological interventions and therapeutic exercises for rheumatoid arthritis: a systematic review and meta-analysis.xlsx by Timothy Adeyemi (22652597)

    Published 2025
    “…Significant effect sizes (0.09 and −0.08) after 24 weeks were equally found in three studies, indicating the reduction in disease activity and an improvement in functionality, respectively. …”
  12. 20312

    Data Sheet 1_Increased levels of ficolin-1 and of C3dg are independently associated with high risk of infection in patients with chronic kidney disease: a prospective cohort study.... by Solbjørg Sagedal (3491267)

    Published 2025
    “…Background and hypothesis<p>Infection is a leading cause of morbidity and mortality in patients with chronic kidney disease (CKD). The complement system provides crucial first-line defense against pathogens. …”
  13. 20313

    Data Sheet 1_Global burden and trend of tuberculosis in children and adolescents (under 15 years old) from 1990 to 2021, with projections to 2040.docx by Yuanhao Liang (8494716)

    Published 2025
    “…From 1990 to 2021, the ASIR declined by 2.4% annually, while ASMR decreased by 4.19% per year. However, drug-resistant TB, especially extensively drug-resistant TB, increased significantly. …”
  14. 20314

    pone.0331193.t003 - by Carol Kotliar (22351525)

    Published 2025
    “…The effects were consistent across various phenotypic factors, such as age, sex, chronic disease distribution, and lifestyle.</p><p>Conclusions</p><p>The MTT24.5 program, based on a systematic algorithm for acquiring new knowledge and skills, significantly enhances cognitive reserve and overall cognitive performance, particularly in individuals with lower baseline cognitive scores. …”
  15. 20315

    Baseline characteristics by group. by Carol Kotliar (22351525)

    Published 2025
    “…The effects were consistent across various phenotypic factors, such as age, sex, chronic disease distribution, and lifestyle.</p><p>Conclusions</p><p>The MTT24.5 program, based on a systematic algorithm for acquiring new knowledge and skills, significantly enhances cognitive reserve and overall cognitive performance, particularly in individuals with lower baseline cognitive scores. …”
  16. 20316

    Data Sheet 1_Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.do... by J.-P. Machiels (22374400)

    Published 2025
    “…Background<p>The health-related quality of life (HRQoL) of patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC) is impacted by both disease- and treatment-related factors. …”
  17. 20317
  18. 20318
  19. 20319

    Recruitment of study participants. by Nashivai Kivuyo (21169036)

    Published 2025
    “…A complete pathological response to neoadjuvant therapy was observed in 40 (22.1%) patients which is relatively lower compared to studies from Western countries. …”
  20. 20320

    Characteristics of the study participants. by Mariama Diédhiou (22582254)

    Published 2025
    “…Participants experienced significant delays between diagnosis and care engagement, often exacerbated by financial constraints or periods of being asymptomatic. …”